{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P15692",
      "entity_text" : "VEGF",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003940",
      "entity_text" : "TGFbeta2",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In models such as EAU and experimental herpesvirus retinopathy, in which VEGF is upregulated early during the course of the disorder, TGFbeta2 has been postulated to inhibit the angiogenic activity of VEGF, accounting for the absence of neovascularization XREF_BIBR, XREF_BIBR.",
  "reading_complete" : "2020-07-28T15:08:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T15:07:37Z",
  "trigger" : "inhibit",
  "evidence" : [ "TGFbeta2 has been postulated to inhibit the angiogenic activity of VEGF" ],
  "pmc_id" : "7119735",
  "score" : 0
}